Profound Medical Corp. (PROF)
USD 5.0
(-6.98%)
USD 5.0
(-6.98%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -18.17 Million USD | 52.52% |
| 2022 | -38.28 Million USD | 41.79% |
| 2021 | -65.77 Million USD | 20.02% |
| 2020 | -82.23 Million USD | -2060.03% |
| 2019 | -3.8 Million CAD | 72.32% |
| 2018 | -13.75 Million CAD | -190.26% |
| 2017 | -4.73 Million CAD | 55.14% |
| 2016 | -10.56 Million CAD | -213.48% |
| 2015 | -3.36 Million CAD | -357.46% |
| 2014 | 1.3 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -33.9 Million USD | -85.77% |
| 2024 Q2 | -27.42 Million USD | 19.2% |
| 2023 Q3 | -25.5 Million USD | 17.7% |
| 2023 Q2 | -30.98 Million USD | 11.05% |
| 2023 Q1 | -34.83 Million USD | 9.01% |
| 2023 Q4 | -18.17 Million USD | 28.71% |
| 2023 FY | -18.17 Million USD | 52.52% |
| 2022 Q3 | -45.1 Million USD | 13.26% |
| 2022 Q2 | -52 Million USD | 11.54% |
| 2022 Q1 | -58.78 Million USD | 10.62% |
| 2022 FY | -38.28 Million USD | 41.79% |
| 2022 Q4 | -38.28 Million USD | 15.12% |
| 2021 Q4 | -65.77 Million USD | 7.05% |
| 2021 Q2 | -72.19 Million USD | 6.11% |
| 2021 Q1 | -76.89 Million USD | 6.49% |
| 2021 Q3 | -70.76 Million USD | 1.98% |
| 2021 FY | -65.77 Million USD | 20.02% |
| 2020 Q1 | -41.99 Million CAD | -1003.03% |
| 2020 Q3 | -80.81 Million CAD | -105.61% |
| 2020 Q4 | -82.23 Million USD | -1.76% |
| 2020 FY | -82.23 Million USD | -2060.03% |
| 2020 Q2 | -39.3 Million CAD | 6.41% |
| 2019 FY | -3.8 Million CAD | 72.32% |
| 2019 Q3 | -9.54 Million CAD | -110.11% |
| 2019 Q1 | -9.42 Million CAD | 31.49% |
| 2019 Q2 | -4.54 Million CAD | 51.78% |
| 2019 Q4 | -3.8 Million CAD | 60.12% |
| 2018 Q2 | -21.5 Million CAD | 18.85% |
| 2018 Q3 | -18.12 Million CAD | 15.7% |
| 2018 Q4 | -13.75 Million CAD | 24.13% |
| 2018 FY | -13.75 Million CAD | -190.26% |
| 2018 Q1 | -26.49 Million CAD | -459.19% |
| 2017 Q1 | -7.48 Million CAD | 29.16% |
| 2017 Q2 | -4.15 Million CAD | 44.51% |
| 2017 Q4 | -4.73 Million CAD | 46.24% |
| 2017 Q3 | -8.81 Million CAD | -112.3% |
| 2017 FY | -4.73 Million CAD | 55.14% |
| 2016 Q1 | -841.18 Thousand CAD | 75.03% |
| 2016 Q2 | 2.42 Million CAD | 387.91% |
| 2016 Q4 | -10.56 Million CAD | -333.78% |
| 2016 Q3 | -2.43 Million CAD | -200.53% |
| 2016 FY | -10.56 Million CAD | -213.48% |
| 2015 Q2 | -16.57 Million CAD | -506.43% |
| 2015 Q1 | 4.07 Million CAD | 338.88% |
| 2015 Q3 | -5.71 Million CAD | 65.54% |
| 2015 Q4 | -3.36 Million CAD | 41.03% |
| 2015 FY | -3.36 Million CAD | -357.46% |
| 2014 FY | 1.3 Million CAD | 0.0% |
| 2014 Q4 | -1.7 Million CAD | -5.0% |
| 2014 Q3 | -1.62 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 167.124% |
| BrainsWay Ltd. | -10.32 Million USD | -76.148% |
| Cerus Corporation | 84.35 Million USD | 121.551% |
| Envoy Medical, Inc. | -3.81 Million USD | -376.626% |
| electroCore, Inc. | -9.95 Million USD | -82.607% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -254.703% |
| IceCure Medical Ltd | -9.93 Million USD | -82.993% |
| Inogen, Inc. | -103.56 Million USD | 82.448% |
| OrthoPediatrics Corp. | -9.26 Million USD | -96.164% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -399.273% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -38.799% |
| MaxCyte, Inc. | -27.76 Million USD | 34.523% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -253.799% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -3057.269% |
| Orthofix Medical Inc. | 96.44 Million USD | 118.849% |
| PAVmed Inc | 29.08 Million USD | 162.499% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | -7.318% |
| RxSight, Inc. | -6.68 Million USD | -172.133% |
| Sight Sciences, Inc. | -102.71 Million USD | 82.302% |
| SI-BONE, Inc. | 5.72 Million USD | 417.751% |
| TELA Bio, Inc. | -3.94 Million USD | -360.332% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 131.714% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 5264.351% |
| Acutus Medical, Inc. | 12.27 Million USD | 248.046% |
| Talis Biomedical Corporation | -57.06 Million USD | 68.144% |
| Spectral AI, Inc. | -3.5 Million USD | -419.238% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 62.149% |
| CVRx, Inc. | -59.95 Million USD | 69.68% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 1016.189% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 1522.823% |
| Bioventus Inc. | 372.51 Million USD | 104.88% |
| Venus Concept Inc. | 74.3 Million USD | 124.466% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -78.536% |
| LivaNova PLC | 62.53 Million USD | 129.071% |
| 908 Devices Inc. | -115.09 Million USD | 84.206% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 105.668% |
| Nemaura Medical Inc. | 9.92 Million USD | 283.159% |
| NeuroPace, Inc. | 54.33 Million USD | 133.455% |
| LENSAR, Inc. | -18.31 Million USD | 0.729% |
| Apyx Medical Corporation | -5.15 Million USD | -252.912% |
| Cutera, Inc. | 288.3 Million USD | 106.305% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 341.896% |
| BioSig Technologies, Inc. | 262 Thousand USD | 7038.365% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 58.525% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -97.614% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 101.294% |
| Axonics, Inc. | -77.19 Million USD | 76.451% |
| Outset Medical, Inc. | 67.67 Million USD | 126.86% |
| IRIDEX Corporation | -4.28 Million USD | -323.939% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 89.788% |
| IRadimed Corporation | -47.71 Million USD | 61.905% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -500.744% |
| INVO Bioscience, Inc. | 8.45 Million USD | 315.101% |
| Telesis Bio, Inc. | 32.63 Million USD | 155.703% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -626.521% |
| Varex Imaging Corporation | 316.9 Million USD | 105.736% |
| Quipt Home Medical Corp. | 81.73 Million USD | 122.241% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -553.433% |
| Pulmonx Corporation | -42.36 Million USD | 57.086% |
| Dynatronics Corporation | 6.2 Million USD | 393.011% |
| Modular Medical, Inc. | -8.04 Million USD | -126.045% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -323.051% |
| Semler Scientific, Inc. | -57.13 Million USD | 68.18% |
| InMode Ltd. | -135.39 Million USD | 86.574% |
| Bruker Corporation | 891.3 Million USD | 102.04% |
| Cytosorbents Corporation | 4.18 Million USD | 534.683% |
| DexCom, Inc. | 2.02 Billion USD | 100.897% |
| Align Technology, Inc. | -840.47 Million USD | 97.837% |
| Viveve Medical, Inc. | -13.81 Million USD | -31.604% |
| ZimVie Inc. | 450.41 Million USD | 104.036% |
| Movano Inc. | -5.86 Million USD | -209.896% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 86.48% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -3057.269% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 1016.189% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 105.095% |
| Insulet Corporation | 798.1 Million USD | 102.278% |
| enVVeno Medical Corporation | -2.21 Million USD | -719.59% |
| Surmodics, Inc. | -12.01 Million USD | -51.311% |
| iCAD, Inc. | -21.2 Million USD | 14.289% |
| Nuwellis, Inc. | -2.81 Million USD | -544.857% |
| Biotricity, Inc. | 23.09 Million USD | 178.72% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 119.411% |
| Aethlon Medical, Inc. | -4.5 Million USD | -303.818% |
| InspireMD, Inc. | -8.04 Million USD | -125.96% |
| PAVmed Inc. | 29.08 Million USD | 162.499% |
| BIOLASE, Inc. | 11.34 Million USD | 260.248% |
| Beyond Air, Inc. | 6.22 Million USD | 391.837% |
| FONAR Corporation | -14.66 Million USD | -23.956% |
| AxoGen, Inc. | 32.26 Million USD | 156.34% |
| Vivani Medical, Inc. | 42 Thousand USD | 43382.179% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -70.562% |
| Inari Medical, Inc. | -7.16 Million USD | -153.854% |
| UFP Technologies, Inc. | 40.77 Million USD | 144.584% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 692.4% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -280.996% |
| Tenon Medical, Inc. | -1.25 Million USD | -1348.487% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -139.002% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -52.424% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.82% |
| Sintx Technologies, Inc. | 905 Thousand USD | 2108.676% |
| NanoVibronix, Inc. | -3.27 Million USD | -454.561% |
| Quanterix Corporation | -132.95 Million USD | 86.328% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -553.433% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 18.719% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 102.412% |
| TransMedics Group, Inc. | 121.13 Million USD | 115.007% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 30.563% |
| NeuroMetrix, Inc. | -1.49 Million USD | -1119.159% |
| Hyperfine, Inc. | -75.61 Million USD | 75.96% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 111.945% |
| Biomerica, Inc. | -3.38 Million USD | -437.031% |
| Bone Biologics Corporation | -3.02 Million USD | -500.631% |
| AVITA Medical, Inc. | -26.23 Million USD | 30.7% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -888.817% |
| Silk Road Medical, Inc | 64.42 Million USD | 128.217% |